The project ¨Training and social awareness for increasing organ donation in the European Union and neighbouring countries¨ (EUDONORGAN) has been launched Blog Post

The main objective of the European project EUDONORGAN, acronym for ‘Training and social awareness for increasing organ donation in the European Union and neighbouring countries’ is to provide training and increase social awareness in the EU and neighbouring countries with the ultimate aim to increase the number of donors. The project  –led by the University of BarcelonaBosch i Gimpera Foundation (UB-FBG) together with the DTI Foundation located at the Barcelona Science Park– is based on two (WPs), Social Awareness and Train the Trainers, the latter coordinated by DTI, which has trained over the last 25 years approximately 13,000 health professionals from more than 100 countries through its International Program TPM.

 

EIT Health Spain awards the best innovation and entrepreneurship projects Blog Post

EIT Health Spain, the Spanish node of EIT Health –the Knowledge and Innovation Community (KIC), dedicated to healthy living and active aging and promoted by the European Institute of Technology and Innovation (EIT)– closed yesterday its first year of activity with an event at the Barcelona Science Park. With headquarters at PCB, EIT Health Spain presently brings together18 leading public and private organizations in the three areas of the innovation triangle in health: research, education and business creation.

 

Arian Internacional succesfully starts a consultancy división for European projects Blog Post

Backed up by 14 years experience and more tan 200 companies  advised on international projects, Arian Internacional–an associate company at the Barcelona Science Park (PCB) – has successfully started the European Projects Advisory/Consultancy service with the preparation of the ZeClinics– that has won funding from the SME Instrument Phase 2, within the framework of  Horizon 2020, under the category  ‘Supporting innovative SMEs in the healthcare biotechnology sector’. This € 1.87 million grant is intended for small and medium-sized European companies investing in innovative projects with a major economic and social impact. 

 

A new study reveals effectiveness of a cognitive enhancer for schizophrenia treatment Blog Post

Researchers from the biotech company Iproteos and the Institute for Research in Biomedicine of Barcelona (IRB Barcelona), member of the Barcelona Institute of Science and Technology (BIST) –based at the Barcelona Science Park–  in collaboration with scientists from the Neuropsychopharmacology Research Group –belonging to the University of Basque Country /Universidad del País Vasco (UPV/EHU) and to the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)– have published an article at European Neuropsychopharmacology, where the new procognitive drug efficacy has been demonstrated for schizophrenia treatment.

 

The Gaem Foundation has been awarded in the 2nd edition of the ‘Somos Pacientes” Awards Blog Post

The ‘Múltiple Esclerosis online’ portal (ME online) of the GAEM Foundation (Group Affected by Multiple Sclerosis), based at the Barcelona Science Park (PCB), has been one of the five projects winners in the second edition of the awards ‘Somos Pacientes‘ (We are Patients), that recognize the effort, dedication, talent and imagination of patient associations to provide assistance, services and solutions to their partners, members and society in general. 

 

Tumour cells are dependent on fat to start metastasis Blog Post

A study headed by Salvador Aznar Benitah, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, and published today in Nature, identifies metastasis-initiating cells through a specific marker, namely the protein CD36. Their results show that the protein CD36, which absorbs fat from the cell membrane, is an essential factor that determines whether tumour cells become metastatic. IRB Barcelona will co-develop antibodies against CD36 with the potential to treat patients.

 

SM Genomics receives the Business and Enterprise Award for Innovation 2016 Blog Post

SM Genomics, located at the Barcelona Science Park, is one of the three companies awarded in the fourth edition of the Business and Sport Awards organized by Indescat –the Catalan Sports Industry Cluster– to recognize the most outstanding projects in the field of innovation, internationalization and partnership. The awards ceremony was held at the Museu Olímpic i de l’Esport Joan Antoni Samaranch and was attended by more than 100 people from the institutional, business and sports world.  

 

New computational method to create drugs more efficiently Blog Post

Researchers of the University of Barcelona proposes in a study published in the scientific journal Nature Chemistry, a new way of facing the discovery of molecules with biological activity. Since it is based on a different principle, this method complements conventional tools and allows going forward in the path of rational drug design. ICREA researcher Xavier Barril, from the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona (IBUB) –located at PCB– has led this project, which has the participation of professor Francesc Xavier Luque and PhD student Sergio Ruiz Carmona, members of the same Faculty. 

 

Structural biologists endorse the potential of their field to extract quality information from big data Blog Post

From the massive data obtained from genomic analysis down to the most intricate details of individual proteins. This is precisely what will be addressed by invited speakers in the next Barcelona Biomed Conference, to be held from today 28 to 30 November at the Institut d’Estudis Catalans. Entitled From genomes to structures: looking at big data with an atomic perspective” and organised by IRB Barcelona, based at PCB, and the BBVA Foundation, this event is the 29th in this series of think-tank gatherings.

 

Minoryx Therapeutics wins the 2016 of Senén Vilaró Prize for best innovative company Blog Post

Minoryx Therapeutics ––located at TecnoCampus Mataró-Maresme, with laboratories at the Barcelona Science Park (PCB)– has won the 2016 Senén Vilaró Prize for best innovative company, one of the four awards conferred by the Board of Trustees of the University of Barcelona and the Bosch i Gimpera Foundation (FBG). The Ramon Margalef Prize of the Board of Trustees to the best article published in a distinguished journal in the field of experimental sciences and health was for Benjamí Oller Salvia, for a  research developed during his doctoral thesis at the Institute for Research in Biomedicine (IRB Barcelona) at the PCB.